HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC – Trademark Portfolio

Entity Type: 16

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HEART VASCULAR & VEIN OF TAMPA BAY. The owner is based in Tampa, FL.

76 Martinique Ave.

Tampa, FL 33606

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC have?

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC file in?

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC's most well-known trademarks?

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC's registered trademark portfolio includes well-known marks such as HEART VASCULAR & VEIN OF TAMPA BAY. These are among 1 currently registered trademark in the portfolio.

What is HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC's trademark registration success rate?

HEART, VASCULAR, AND VEIN OF TAMPA BAY, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.